GARUTI, ANNA
 Distribuzione geografica
Continente #
EU - Europa 8.186
AS - Asia 762
NA - Nord America 408
SA - Sud America 73
AF - Africa 16
OC - Oceania 5
Totale 9.450
Nazione #
IT - Italia 8.023
US - Stati Uniti d'America 397
SG - Singapore 302
CN - Cina 204
VN - Vietnam 164
FR - Francia 60
BR - Brasile 43
HK - Hong Kong 28
DE - Germania 25
AR - Argentina 21
FI - Finlandia 14
GB - Regno Unito 13
BD - Bangladesh 12
IQ - Iraq 11
IN - India 10
JP - Giappone 10
NL - Olanda 7
UA - Ucraina 7
CH - Svizzera 6
ES - Italia 6
RU - Federazione Russa 6
EC - Ecuador 5
AU - Australia 4
CA - Canada 4
ID - Indonesia 4
IE - Irlanda 4
MX - Messico 4
SE - Svezia 4
ZA - Sudafrica 4
TR - Turchia 3
UZ - Uzbekistan 3
AL - Albania 2
KE - Kenya 2
MA - Marocco 2
NG - Nigeria 2
PA - Panama 2
PK - Pakistan 2
TN - Tunisia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
JO - Giordania 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PF - Polinesia Francese 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
Totale 9.450
Città #
Genova 4.762
Genoa 2.020
Rapallo 731
Vado Ligure 479
Singapore 129
San Jose 125
Ashburn 101
Lauterbourg 53
Ho Chi Minh City 47
Beijing 44
Hanoi 28
Hong Kong 27
Council Bluffs 25
Frankfurt am Main 23
Santa Clara 15
Helsinki 14
Los Angeles 13
Da Nang 12
Bordighera 11
Haiphong 11
New York 11
Tokyo 9
Kyiv 6
Orem 6
Zurich 6
Amsterdam 5
Biên Hòa 5
Atlanta 4
Cardiff 4
Chicago 4
London 4
Paris 4
Stockholm 4
São Paulo 4
Tianjin 4
Baghdad 3
Buenos Aires 3
Can Tho 3
Dublin 3
Johannesburg 3
Madrid 3
Mexico City 3
Rio de Janeiro 3
Sydney 3
Thái Bình 3
Turin 3
Ankara 2
Charlotte 2
Chennai 2
Dallas 2
Denver 2
Des Moines 2
Dhaka 2
Guayaquil 2
Hải Dương 2
Karbala 2
Nairobi 2
Nha Trang 2
Panama City 2
Quảng Ngãi 2
Quận Ba 2
Rome 2
São Carlos 2
Tirana 2
Tunis 2
Vĩnh Long 2
Vĩnh Tường 2
Abidjan 1
Acalanes Ridge 1
Accra 1
Addis Ababa 1
Agadir 1
Ahmedabad 1
Aktobe 1
Amman 1
Anápolis 1
Aracaju 1
Araraquara 1
Athens 1
Avellaneda 1
Baku 1
Basingstoke 1
Basra 1
Belgrade 1
Belo Horizonte 1
Belén de Escobar 1
Benito Juarez 1
Besançon 1
Bhopal 1
Birmingham 1
Boulogne-Billancourt 1
Braga 1
Brisbane 1
Brussels 1
Buffalo 1
Bình Dương 1
Bắc Giang 1
Bắc Ninh 1
Cabo Frio 1
Cabreúva 1
Totale 8.858
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 257
APO866 activity in hematologic malignancies: a preclinical in vitro study. 245
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 245
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 216
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 200
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation 200
Ras-induced resistance to lapatinib is overcome by MEK inhibition 199
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 199
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 197
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 192
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 190
Uncovering the genomic heterogeneity of multifocal breast cancer 190
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 189
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 189
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 187
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 186
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 186
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 182
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 182
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 180
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 180
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 178
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 174
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 173
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 172
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 172
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 171
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 171
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 171
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 169
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 169
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 167
High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas. 167
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 165
Mutant presenilin 1 increases the expression and activity of BACE1. 164
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. 163
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 160
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 156
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 155
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 154
Germline mutations in the von Hippel-Lindau gene in Italian patients. 149
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling 149
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 148
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 146
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 145
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 143
Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples. 137
Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia 134
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer 125
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 123
The role of alpha-interferon in chronic myelogenous leukaemia in imatinib era. 119
Mutational analysis of BRCA1 and BRCA2 genes in high grade serous ovarian carcinoma with Next Generation Sequencing (NGS); correlation between somatic and germline mutations 119
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 111
Transcriptome Sequencing Of The Transition From Normal Epithelium To Invasive Cancer Reveals Insights Into The Carcinogenesis Of Hpv+ And Hpv- Vulvar Neoplasia 111
β-amyloid 1-42 induces physiological transcriptional regulation of BACE1. 100
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer 87
Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer 79
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis 56
Totale 9.543
Categoria #
all - tutte 28.404
article - articoli 27.291
book - libri 0
conference - conferenze 754
curatela - curatele 0
other - altro 359
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 0 0 0 0 58 55 35
2021/2022789 28 59 66 110 28 50 52 168 34 63 46 85
2022/2023896 93 98 10 100 147 121 10 64 133 1 112 7
2023/2024487 20 53 4 69 33 98 19 38 19 18 37 79
2024/20251.307 47 85 43 90 151 110 116 278 37 51 137 162
2025/20262.012 297 63 118 159 354 164 344 118 181 214 0 0
Totale 9.543